Diabetic Foot & Wound Care in Cuba for U.S. Patients
Over 37 million Americans have diabetes, and 15–25% will develop a foot ulcer in their lifetime. Cuba offers Heberprot-P — a recombinant epidermal growth factor injected directly into diabetic foot ulcers to promote healing — combined with comprehensive wound care and amputation prevention. Not FDA-approved, not available in the United States.
Clinical Research Basis
Patient Safety First
Expert Medical Teams
International Standards
Diabetic Foot & Wound Care — Treatment Topics
Explore Diabetic Foot & Wound Care Treatment Options
Each topic below provides in-depth information about Cuba's diabetic foot & wound care treatment approach, with state-specific pages for 10 high-priority U.S. states.
State-by-State Guide
Diabetic Foot & Wound Care by U.S. State
We've prioritized the 10 U.S. states with the highest diabetes rates. Each state page includes local statistics, travel logistics, and state-specific context.
Frequently Asked Questions
Questions from American Families
Yes. U.S. citizens can travel to Cuba under approved categories. SMC Salud provides all necessary documentation, including the letter of medical necessity and treatment confirmation, to support travel authorization. Our team guides you through the entire process to ensure compliance with all regulations.
Ready to Explore Diabetic Foot & Wound Care Treatment in Cuba?
Submit your medical records for a complimentary review by Cuba's medical team. Receive a personalized treatment proposal within 5–10 business days — no obligation to travel.